IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 701–800 of 1,002
Althof, N., & Whitton, J. L. (2012) · Journal of Virology · doi:10.1128/jvi.03004-12 · Cited by 23
Poulin, L. F., Lasseaux, C., & Chamaillard, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00823 · Cited by 24
Epidermal Stem Cells and Their Epigenetic Regulation
Shen, Q., Jin, H., & Wang, X. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917861 · Cited by 21
“Proponents propose that it is a reasonable way to explain the proliferative heterogeneity previously reported in epidermis—slow-cycling epidermal stem cells can switch rapidly and reversibly between quiescence and activation following injury or drug treatments [23].”
BackgroundPiątek, P., Tarkowski, M., Namiecińska, M., Riva, A., Wieczorek, M., Michlewska, S., Dulska, J., Domowicz, M., Michalska, M. K. , Lewkowicz, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682094 · Cited by 22
IgE cross-linking induces activation of human and mouse mast cell progenitors
Méndez-Enríquez, E., Salomonsson, M., Eriksson, J., Janson, C., Malinovschi, A., Sellin, M. E., & Hallgren, J. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.019 · Cited by 21
Role of Circular RNAs in Pulmonary Fibrosis
Zhou, J. P., Chen, Y., He, M., Li, X., & Wang, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810493 · Cited by 21
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
Grusanovic, S., Daněk, P., Kuzmina, M., Adamcova, M. K., Burócziová, M., Mikyšková, R., Vanickova, K., Kosanovic, S., Pokorna, J., Reiniš, M., et al. (2022) · EMBO Reports · doi:10.15252/embr.202254729 · Cited by 22
“…and impose quiescence, excessive exposure to inflammatory cytokines may lead to impaired self-renewal and increased differentiation, thus compromising HSC function (Essers et al , 2009; Baldridge et al , 2010; Chen et al , 2010; Boettcher et al , 2012; Kunisaki et al , 2013; Helbling et al , 2019).”
Zhao, H., & Deininger, M. W. (2023) · Blood · doi:10.1182/blood.2022017152 · Cited by 23
New insight into the causes, consequences, and correction of hematopoietic stem cell aging
Mansell, E., Lin, D. S. Y., Loughran, S. J., Milsom, M. D., & Trowbridge, J. J. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.07.002 · Cited by 24
Transcripts of repetitive DNA elements signal to block phagocytosis of hematopoietic stem cells
Rodrigues, C. P., Collins, J. M., Yang, S. P., Martinez, C., Kim, J. W., Lama, C., Nam, A. S., Alt, C., Lin, C. P., & Zon, L. I. (2024) · Science · doi:10.1126/science.adn1629 · Cited by 23
Istvánffy, R., Vilne, B., Schreck, C., Ruf, F., Pagel, C., Grziwok, S., Henkel, L., da Costa, O. P., Berndt, J., Stümpflen, V., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.09.018 · Cited by 24
“Under steadystate conditions, HSCs are maintained as slow-dividing clones of quiescent cells (Wilson et al., 2009), whereas during states of stress, for instance those in which interferons are induced, HSCs are rapidly recruited into the cell cycle (Essers et al., 2009).”
BackgroundPrick, J. C. M., de Haan, G., Green, A. R., & Kent, D. G. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.07.268 · Cited by 23
“Recently, it was shown that in addition to achieving normalization of blood counts, IFN-α also reduced JAK2V617F allelic burden [90, 91] and activated the cell cycle machinery in quiescent mutant HSC populations [92, 93].”
BackgroundTrilling, M., Le‐Trilling, V. T. K., & Hengel, H. (2012) · Future Microbiology · doi:10.2217/fmb.12.109 · Cited by 22
How hematopoietic stem/progenitors and their niche sense and respond to infectious stress
Kobayashi, H., Suda, T., & Takubo, K. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.11.008 · Cited by 22
Blimp-1/PRDM1 is a critical regulator of Type III Interferon responses in mammary epithelial cells
Élias, S., Robertson, E. J., Bikoff, E. K., & Mould, A. W. (2018) · Scientific Reports · doi:10.1038/s41598-017-18652-9 · Cited by 22
Luteinizing hormone signaling restricts hematopoietic stem cell expansion during puberty
Peng, Y. J., Yu, H. T., Hao, X., Dong, W., Yin, X., Lin, M., Zheng, J., & Zhou, B. O. (2018) · The EMBO Journal · doi:10.15252/embj.201898984 · Cited by 22
“Besides local microenvironment, upon infection, systemic IFNa promotes the exit of HSCs out of the dormant stage, partially through its receptor IFNAR on HSCs (Essers et al, 2009).”
BackgroundHematopoietic stem and progenitor cells are present in healthy gingiva tissue
Krishnan, S., Wemyss, K., Prise, I. E., McClure, F. A., O’Boyle, C., Bridgeman, H. M., Shaw, T. N., Grainger, J. R., & Konkel, J. E. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200737 · Cited by 21
Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?
Saifullah, H. H., & Lucas, C. (2021) · Cancers · doi:10.3390/cancers13164175 · Cited by 23
Rodrigues, C. P., & Akhtar, A. (2021) · Science Advances · doi:10.1126/sciadv.abi5987 · Cited by 21
Vaughan, K., Franchini, A. M., Kern, H. G., & Lawrence, B. P. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0096 · Cited by 21
Biological therapy and the immune system in patients with chronic myeloid leukemia
Rohoň, P. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1116-8 · Cited by 22
Necroinflammation emerges as a key regulator of hematopoiesis in health and disease
Jost, P. J., & Höckendorf, U. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0194-4 · Cited by 22
Inflammatory signals in HSPC development and homeostasis: Too much of a good thing?
Luis, T. C., Tremblay, C. S., Manz, M. G., North, T. E., King, K. Y., & Challen, G. A. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.06.254 · Cited by 22
The added value of type I interferons to cytotoxic treatments of cancer
Bracci, L., Sistigu, A., Proietti, E., & Moschella, F. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.008 · Cited by 21
Inflammation in myelodysplastic syndrome pathogenesis
Rodríguez‐Sevilla, J. J., & Colla, S. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.09.005 · Cited by 20
Chattopadhyay, S., Chatterjee, R., & Law, S. K. A. (2015) · Environmental Toxicology · doi:10.1002/tox.22123 · Cited by 20
“Thus, downregulated Wnt5a severely hampered HSCs reconstitution ability upon prolonged xenobiotic stress resulting in poor hematopoietic recovery in aplasia BM.”
BackgroundInfluentialThe Adaptive Remodeling of Stem Cell Niche in Stimulated Bone Marrow Counteracts the Leukemic Niche
Jeong, S., Kim, J., & Oh, I. (2018) · Stem Cells · doi:10.1002/stem.2870 · Cited by 20
Jia, R., & Královics, R. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02778-9 · Cited by 22
Uckelmann, H. J., & Armstrong, S. A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.013 · Cited by 21
“…balance between the various blood cell lineages can be acutely altered by environmental factors, such as stress, inflammation, or blood loss, to provide an emergency supply of certain blood and immune cells (Essers et al., 2009; Haas et al., 2015; King and Goodell, 2011; Walter et al., 2015).”
BackgroundRecent Progress in Interferon Therapy for Myeloid Malignancies
Healy, F. M., Dahal, L. N., Jones, J. R. E., Fløisand, Y., & Woolley, J. F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769628 · Cited by 20
Frascoli, M., Proietti, M., & Grassi, F. (2012) · Journal of Visualized Experiments · doi:10.3791/3736-v · Cited by 20
Extrinsic regulation of hematopoietic stem cells in development, homeostasis and diseases
Lee, Y., Decker, M., Lee, H. J., & Ding, L. (2017) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.279 · Cited by 23
The role of driver mutations in myeloproliferative neoplasms: insights from mouse models
Shide, K. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02803-x · Cited by 20
Watanuki, S., Kobayashi, H., Sugiura, Y., Yamamoto, M., Karigane, D., Shiroshita, K., Sorimachi, Y., Fujita, S., Morikawa, T., Koide, S., et al. (2024) · eLife · doi:10.7554/elife.87674 · Cited by 22
Stem cell decoupling underlies impaired lymphoid development during aging
Jang, G., Contreras, S., Esteva, E., Upadhaya, S., Feng, J., Adams, N. M., Richard, É., Awatramani, R. B., Sawai, C. M., & Reizis, B. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302019120 · Cited by 20
Imitola, J., Hollingsworth, E. W., Watanabe, F., Olah, M., Elyaman, W., Starossom, S. C., Kivisäkk, P., & Khoury, S. J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1156802 · Cited by 20
“Interferons have been shown to activate hematopoietic stem cell (HSC) self-renewal by inducing proliferation in response to infections (Essers et al., 2009; Baldridge et al., 2010); however, their role in the brain is still not clear.”
BackgroundDiscovering adaptive features of innate immune memory
Sadeghi, M., & Divangahi, M. (2024) · Immunological Reviews · doi:10.1111/imr.13328 · Cited by 22
Alsultan, A. S., Farge, D., Kili, S., Forte, M., Weiss, D. J., Grignon, F., & Boelens, J. J. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.007 · Cited by 21
Kim, K., & McBride, W. H. (2010) · Current Drug Targets · doi:10.2174/1389450111009011352 · Cited by 20
Label retaining cells in cancer – The dormant root of evil?
Schillert, A., Trumpp, A., & Sprick, M. R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.019 · Cited by 22
“After re-establishment of homeostasis the activated cells may re-enter a dormant state [38,39].”
BackgroundSelf-citationKadmon, C. S., Landers, C. T., Li, H. S., Watowich, S. S., Rodríguez, A., & King, K. Y. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.09.001 · Cited by 20
Klose, M., Florian, M. C., Gerbaulet, A., Geiger, H., & Glauche, I. (2019) · Stem Cells · doi:10.1002/stem.3005 · Cited by 19
“Depletion of cells is commonly initiated by cytotoxic treatments or by irradiation followed by transplantation of donor cells whose contribution to hematopoiesis is subsequently measured (Essers et al., 2009; Osawa et al., 1996; Wichmann and Loeffler, 1985; Wilson et al., 2008; Wilson et al., 2009).”
BackgroundSoto, C. A., Celso, C. L., Purton, L. E., & Frisch, B. J. (2021) · JBMR Plus · doi:10.1002/jbm4.10516 · Cited by 21
Microbial Sensing by Hematopoietic Stem and Progenitor Cells
Barman, P. K., & Goodridge, H. S. (2022) · Stem Cells · doi:10.1093/stmcls/sxab007 · Cited by 20
Stem cell homeostasis by integral feedback through the niche
Becker, N. B., Günther, M., Li, C., Jolly, A., & Höfer, T. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.12.029 · Cited by 21
Single Cell Phenotyping Reveals Heterogeneity Among Hematopoietic Stem Cells Following Infection
MacLean, A. L., Smith, M. A., Liepe, J., Sim, A., Khorshed, R., Rashidi, N. M., Scherf, N., Krinner, A., Roeder, I., Celso, C. L., et al. (2017) · Stem Cells · doi:10.1002/stem.2692 · Cited by 23
Stemming out of a new PML era?
Salomoni, P. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.63 · Cited by 21
“of dormant HSCs and sensitizes them to chemotherapeutic agents.(38) As PML is a target of IFNs, it would be very interesting to determine whether PML plays any part in mediating IFNa-dependent effects and whether there would”
BackgroundThe bone marrow hematopoietic niche and its adaptation to infection
Gomes, A. C., Saraiva, M., & Gomes, M. S. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.05.014 · Cited by 18
Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model
Reinitz, F., Chen, E. Y., Nicolis di Robilant, B., Chuluun, B., Antony, J., Jones, R. C., Gubbi, N., Lee, K., Ho, W. H. D., Kolluru, S. S., et al. (2022) · eLife · doi:10.7554/elife.66037 · Cited by 18
Function of hematopoiesis and bone marrow niche in inflammation and non-hematopoietic diseases
Wang, Y., Deng, Z., Li, Y.-Y., Bai, K., Ma, J., Liu, Y., & Chen, Q. (2025) · Life Medicine · doi:10.1093/lifemedi/lnaf015 · Cited by 21
Decoding the adaptive survival mechanisms of breast cancer dormancy
Barnieh, F. M., MORTON, J. K., Olanrewaju, O., & El‐Khamisy, S. F. (2025) · Oncogene · doi:10.1038/s41388-025-03529-3 · Cited by 21
Molecular and cellular bases of trained immunity
Sun, S. J., Aguirre‐Gamboa, R., & Barreiro, L. B. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.001 · Cited by 20
Hermetet, F., Mshaik, R., Simonet, J., Callier, P., Delva, L., & Quéré, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-73020-4 · Cited by 18
Greenberg, Z. J., Paracatu, L. C., Monlish, D. A., Dong, Q., Rettig, M. P., Roundy, N., Gaballa, R., Li, W., Yang, W., Luke, C. J., et al. (2022) · Blood · doi:10.1182/blood.2022016929 · Cited by 19
ADP-Ribosylation in Antiviral Innate Immune Response
Du, Q., Miao, Y., He, W., & Zheng, H. (2023) · Pathogens · doi:10.3390/pathogens12020303 · Cited by 22
Grb2 regulates the proliferation of hematopoietic stem and progenitors cells
Frelin, C., Ofran, Y., Ruston, J., Hayun, M., Ofir, Y. D., Khier, Y., Rozales, K., Brenner, B., Iscove, N. N., Pawson, T. J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.09.018 · Cited by 22
Doherty, M. R., & Jackson, M. W. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4247 · Cited by 18
“High doses of IFN can repress tumor cell–intrinsic proliferation and induce cell death, both in vitro using cancer cell lines as well as in vivo using patient-derived tumor cells (Essers et al., 2009; Parker et al., 2016; Brockwell et al., 2017).”
BackgroundMethodE-Cigarette Exposure Decreases Bone Marrow Hematopoietic Progenitor Cells
Ramanathan, G., Hoover, B., Arechavala, R. J., Herman, D. A., Chen, J. H., Lai, H. Y., Renusch, S. R., Kleinman, M. T., & Fleischman, A. G. (2020) · Cancers · doi:10.3390/cancers12082292 · Cited by 20
Chronic inflammation can transform the fate of normal and mutant hematopoietic stem cells
Li, J., Malouf, C., Miles, L. A., Willis, M., Pietras, E. M., & King, K. Y. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.08.008 · Cited by 18
Hematopoietic stem cells: interplay with immunity.
Zhang, C. C. (2012) · PubMed · Cited by 20
Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation
Jones, M., Osawa, G., Regal, J. A., Weinberg, D. N., Taggart, J., Kocak, H., Friedman, A., Ferguson, D. O., Keegan, C. E., & Maillard, I. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67871 · Cited by 18
“was shown to drive quiescent HSCs into the cell cycle, which could enhance the impact of TPP1 loss in hematopoietic progenitors (39).”
Chang, K. H., Nayak, R. C., Roy, S., Perumbeti, A., Wellendorf, A. M., Lamm, K. Y. B., Pirman, M., Kargbo-Hill, S. E., Starnes, J. R., Loberg, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms6914 · Cited by 19
Regulation of Hematopoietic Stem Cell Fate and Malignancy
Cho, H. J., Lee, J., Yoon, S. R., Lee, H. G., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134780 · Cited by 21
IRF2 maintains the stemness of colonic stem cells by limiting physiological stress from interferon
Minamide, K., Sato, T., Nakanishi, Y., Ohno, H., Kato, T., Asano, J., & Ohteki, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-71633-3 · Cited by 18
Suppression of thrombospondin-1–mediated inflammaging prolongs hematopoietic health span
Ramalingam, P., Gutkin, M. C., Poulos, M. G., Winiarski, A., Smith, A., Carter, C., Doughty, C., Tillery, T., Redmond, D., Freire, A. G., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ads1556 · Cited by 17
Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential
Zhang, C., Hao, T., Bortoluzzi, A., Chen, M.-H., Wu, X., Wang, J., Ermel, R. W., Kim, Y., Chen, S., & Chen, W. (2024) · Oncogene · doi:10.1038/s41388-024-03197-9 · Cited by 20
Fotopoulou, F., Rodriguez-Correa, E., Dussiau, C., & Milsom, M. D. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104698 · Cited by 19
Hayashi, T., Ding, Q., Kuwahata, T., Maeda, K., Miyazaki, Y., Matsubara, S., Obara, T., Natsugoe, S., & Takao, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02235.x · Cited by 17
Bourdeau, A., Trop, S., Doody, K. M., Dumont, D., & Tremblayef, M. L. (2012) · Stem Cells · doi:10.1002/stem.1276 · Cited by 17
Type I interferons drive inflammasome-independent emergency monocytopoiesis during endotoxemia
Lasseaux, C., Fourmaux, M.-P., Chamaillard, M., & Poulin, L. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-16869-2 · Cited by 19
Developmental HSC Microenvironments: Lessons from Zebrafish
Nik, S., Weinreb, J. T., & Bowman, T. V. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69194-7_4 · Cited by 17
“This response of HSCs is not a secondary outcome to the loss of immune cells, but rather a direct response to inflammatory cytokines (Baldridge et al. 2010; Essers et al. 2009).”
BackgroundZhang, H., Li, H. S., Hillmer, E. J., Zhao, Y., Chrisikos, T. T., Hu, H., Wu, X. Y., Thompson, E. J., Clise-Dwyer, K., Millerchip, K. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713889115 · Cited by 21
Mechanisms of oncogenic cell competition–Paths of victory
Gutiérrez-Martínez, A., Sew, W. Q. G., Molano-Fernández, M., Carretero, M., & Herranz, H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.015 · Cited by 20
Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches
Lévesque, J.-P., SUMMERS, K. M., Millard, S. M., Bisht, K., Winkler, I. G., & Pettit, A. R. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.07.001 · Cited by 17
Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies
Ye, B., Sheng, Y., Zhang, M., Hu, Y., & Huang, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215691 · Cited by 18
Johnson‐Ansah, H., Guilhot, J., Rousselot, P. H., Réa, D., Legros, L., Huguet, F., Nicolini, F. E., Mahon, F., Preudhomme, C., & Guilhot, F. (2013) · Cancer · doi:10.1002/cncr.28328 · Cited by 17
Awaking stem cells from dormancy: growing old and fighting cancer
Viale, A., & Pelicci, P. G. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900019 · Cited by 20
“Two recent studies by Andreas Trumpp’s group (Essers et al, 2009; Wilson et al, 2008) address some of these issues, while opening, as often happens, new ones.”
BackgroundInfluentialHardan, I., Stanevsky, A., Volchek, Y., Tohami, T., Amariglio, N., Trakhtenbrot, L., Koren‐Michowitz, M., Shimoni, A., & Nagler, A. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.018 · Cited by 17
Zheng, H., Zhang, M., Chen, M., Jiang, J., Song, J.-H., Lian, X., Tian, R., Zhang, X.-L., Zhang, L., Pang, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00084-0 · Cited by 17
“Interestingly, SOCS1, which encodes a member of cytokine-inducible negative regulators of cytokine signaling that act as modulators of IFN-γ action (ENTREZ gene summary), was slightly induced by SIVmac239 in ChRM but was quickly down-regulated in old macaques.”
BackgroundJanečková, L., Kostovcikova, K., Švec, J., Šťastná, M., Strnad, H., Kolář, M., Hudcovic, T., Stančíková, J., Turečková, J., Dibus, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071581 · Cited by 18
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Charaf, L., Mahon, F.-X., Lamrissi-Garcia, I., Moranvillier, I., Beliveau, F., Cardinaud, B., Dabernat, S., de Verneuil, H., Moreau-Gaudry, F., & Bedel, A. (2017) · Leukemia · doi:10.1038/leu.2016.154 · Cited by 16
Inflammation and hematopoietic stem cells aging
He, H., & Wang, J. (2020) · Blood Science · doi:10.1097/bs9.0000000000000063 · Cited by 19
Inflammatory platelet production stimulated by tyrosyl-tRNA synthetase mimicking viral infection
Morodomi, Y., Kanaji, S., Sullivan, B. M., Zarpellon, A., Orje, J. N., Won, E., Shapiro, R., Yang, X., Ruf, W., SCHIMMEL, P. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212659119 · Cited by 27
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing
Castiello, M. C., Ferrari, S., & VILLA, A. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101731 · Cited by 17
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
Pallavi, R., Gatti, E., Durfort, T., Stendardo, M., Ravasio, R., Leonardi, T., Falvo, P., Duso, B. A., Punzi, S., Xieraili, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44348-y · Cited by 18
“Interferons are potent inducers of normaland leukemic SC-exhaustion 41,42 , suggesting that decreased IFN signaling may preserve LIC function upon CR, leading to the observed LIC increase.”
Neonatal hyperoxia leads to persistent alterations in NK responses to influenza A virus infection
Reilly, E. C., Martin, K. C., Jin, G., Yee, M., O’Reilly, M. A., & Lawrence, B. P. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00233.2014 · Cited by 17
Silver, R. T., & Hasselbalch, H. C. (2016) · Hematology · doi:10.1080/10245332.2015.1111644 · Cited by 16
Eit, R. E., Itani, A. R., Nassar, F. J., Rasbieh, N. G., Jabbour, M. N., Santina, A., Zaatari, G. S., Mahon, F., Bazarbachi, A. A., & Nasr, R. (2019) · Cancer · doi:10.1002/cncr.32130 · Cited by 16
Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmström, M. O., Andersen, M. H., Svane, I. M., Mikkelsen, S. U., Skov, V., Kjær, L., Hasselbalch, H. C., et al. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13292 · Cited by 16
Robino, J. J., Pamir, N., Rosário, S., Crawford, L. B., Burwitz, B. J., Roberts, C. T., Kurre, P., & Varlamov, O. (2020) · Bone · doi:10.1016/j.bone.2020.115248 · Cited by 17
Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view
Hasaart, K., Bertrums, E. J. M., Manders, F., Goemans, B. F., & van Boxtel, R. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.6 · Cited by 20
Jäger, P. S., Geyh, S., Twarock, S., Cadeddu, R., Rabes, P., Koch, A., Maus, U. M., Hesper, T., Zilkens, C., Rautenberg, C., et al. (2021) · Stem Cells · doi:10.1002/stem.3387 · Cited by 17
Li, D., Zhang, Y., Qiu, Q., Wang, J., Zhao, X., Jiao, B., Zhang, X., Yu, S., Xu, P., Dan, Y., et al. (2021) · Advanced Science · doi:10.1002/advs.202101031 · Cited by 19
The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
de Castro, C. P. M., Cadefau-Fabregat, M., & Cuartero, S. (2021) · Cancers · doi:10.3390/cancers13164144 · Cited by 18
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
Aprile, A., Sighinolfi, S., Raggi, L., & Ferrari, G. (2022) · Pharmaceuticals · doi:10.3390/ph15050592 · Cited by 19
Ross, E. A., Flores‐Langarica, A., Bobat, S., Coughlan, R. E., Marshall, J. L., Hitchcock, J. R., Cook, C. N. L., Carvalho‐Gaspar, M., Mitchell, A. M., Clarke, M. L., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344350 · Cited by 16
Identification of in vitro HSC fate regulators by differential lipid raft clustering
Vannini, N., Roch, A., Naveiras, O., Griffa, A., Kobel, S., & Lütolf, M. P. (2012) · Cell Cycle · doi:10.4161/cc.19900 · Cited by 18
Saka, K., Kawahara, M., Ueda, H., & Nagamune, T. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24421 · Cited by 16
“These 1530 Biotechnology and Bioengineering, Vol. 109, No. 6, June, 2012 molecules play an important role in intracellular signal transduction activated by various cytokine receptors (Kato et al., 2005; Chung et al., 2006; Essers et al., 2009; Perry et al., 2011).”
BackgroundDu, J., Wang, J., Kong, G., Jiang, J. T., Zhang, J., Liu, Y., Tong, W., & Zhang, J. (2012) · Stem Cells · doi:10.1002/stem.1127 · Cited by 16
Libregts, S. F. W. M., & Nolte, M. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.016 · Cited by 20
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.